Two Sigma Investments, LP Rezolute, Inc. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Rezolute, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 59,463 shares of RZLT stock, worth $266,988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,463
Previous 71,581
16.93%
Holding current value
$266,988
Previous $347,000
18.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$50.6 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$12.8 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$12.6 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$11.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$10.4 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $174M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...